Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Eisai's US subsidiary, Eisai Inc., has announced plans to re-locate its US headquarters in Woodcliff Lake, New Jersey to the former Roche headquarters campus in Nutley, New Jersey. The move is expected to be completed in late 2021 and will transfer...

Bayer has agreed to acquire KaNDy Therapeutics, a Stevenage, UK-based clinical-stage biopharmaceutical company, to expand its drug-development pipeline in women’s healthcare, in a deal worth up to $875 million. KaNDy Therapeutics recently...

A roundup of news from Germany (Evotec, Secarna Pharmaceuticals, CureVac), Japan (Teva, Takeda), and the US (Astellas, Sorrento Therapeutics, and SRI Biosciences). Germany Evotec, Secarna Pharmaceuticals in Pact for Antisense...

Merck & Co. and Hanmi Pharmaceutical, a Seoul, South Korea-based pharmaceutical company, have formed an exclusive licensing agreement, in a deal worth up to $870 million, for the development, manufacture and commercialization of efinopegdutide,...

Elanco Animal Health, the former animal-health business of Eli Lilly and Company and now a stand-alone company, has closed its $6.89-billion acquisition of Bayer Animal Health. The companies signed an agreement for the acquisition in August 2019....